New Strategies in the Treatment of Follicular Lymphoma: 2022 ASH Update
Released on 12/30/22
on 12/30/23

Emerging Strategies in the Treatment of Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma
Released on 12/8/22
Expires on 12/8/23

Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy
Released on 10/21/22
Expires on 10/21/23

Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma
Released on 9/14/22
on 9/14/23

Emerging Treatment Options for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Released on 6/24/22
Expires on 6/24/23

Current and New Biomarkers and Targeted Therapy Options for Gastric and Gastroesophageal Junction Cancers
Released on 5/20/22
Expires on 5/20/23

Current and Emerging Treatment Options for Multiple Myeloma
Released on 4/7/22
Expires on 4/7/23

Novel Treatment Options for Multiple Myeloma
Released on 3/24/22
Expires on 3/24/23

New and Emerging Treatment Options for Hematological Malignancies
Released on 12/30/21
Expires on 12/30/22

Evolving Strategies in the Treatment of HER2-positive Metastatic Breast Cancer with Antibody-Drug Conjugates and Tyrosine Kinase Inhibitors
Released on 12/8/21
Expires on 12/8/22

Emerging Strategies in the Management of Genitourinary Cancers
Released on 11/22/21
Expires on 11/22/22

Novel Therapies for Metastatic Castrate Resistant Prostate Cancer with PARP-Inhibitors and BITE Immunotherapy
Released on 11/8/21
Expires on 11/8/2

Emerging Treatment Options for BRAF-mutant Colorectal Cancer
Released on 9/9/21
Expires on 9/9/22

Changing Landscape of Treatment for Acute Lymphoblastic Leukemia
Released on May 26, 2021
Expires on May 26, 2022

Biosimilars: Implications for Clinical Practice in Hematological Malignancies & Supportive Care
Released on 4/30/21
Expires on 4/30/22

Update on the Immune Checkpoint Inhibitor and Combination Targeted Therapies for Hepatocellular Carcinoma
Released on 3/18/20
Expires on 3/18/21

Changing Landscape of NSCLC with Targeted Therapies and Immunotherapy
Released on 12/08/20
Expires on 12/08/21

Advances in the Treatment of dMMR/MSI-H Colorectal Cancer with Immunotherapy
Released on 12/05/20
Expires on 12/05/21

Changing Landscape of Treatment Options for Multiple Myeloma
Released on 10/5/20
Expires on 10/5/21

Changing Landscape of Treatment Options for Hematological Malignancies
Released on 9/28/20
Expires on 9/28/21

Current and Emerging Treatment Options for Renal Cell Carcinoma
Released on 10/10/20
Expires on 10/18/21

Current and Emerging Treatment Options for Lung Cancer and Head & Neck Cancer
Released on 7/22/21
Expires on 7/30/21

Current and Emerging Treatment Options for Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma)
Released on 6/15/20
Expires on 6/15/21

Changing Landscape of Treatment Options for Metastatic Urothelial Carcinoma
Released on 5/22/20
Expires on 5/22/21

New Paradigms in the Treatment of Relapsed Multiple Myeloma 
Released on 5/3/20
Expires on 5/3/21

New Paradigms in the Treatment Options for Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML): European Perspective
Released on 4/28/20
Expires on 4/28/21

Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma
Released on 12/30/19
Expires on 12/30/20

Changing Landscape of Treatment of HR+ and HER2- Metastatic Breast Cancer with PI3K and CDK 4/6 Inhibitors
Released on 12/26/19
Expires on 12/26/20

Changing Landscape of Treatment Options for ALL with CD19, CD22 Monoclonal Antibodies and AML with IDH1/2, FLT3, CD33 and Hedgehog Pathway Targeted Agents
Released on 9/17/19
Expires on 9/17/20

Evolving Landscape of Treatment for Hepatocellular Carcinoma with Multi-Targeted Tyrosine Kinase Inhibitors and Immunotherapy
Released on 6/24/19
Expires on 6/24/20

Changing Landscape of Targeted and Immunotherapies for Genitourinary Cancers
Released on 6/12/19
Expires on 6/12/20

Changing Treatment Landscape of Metastatic Head and Neck Squamous Cell Carcinoma with Anti-PD-1/PD-L1 Agents
Released on 6/10/19
Expires on 6/10/20

New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia
Released on 5/13/19
Expires on 5/13/20

Optimizing Outcomes in Patients with Malignant Melanoma Treated with Targeted Agents, Checkpoint Inhibitors and Oncolytic Viral Therapies
Released on 12/30/18
Expires on 12/30/19

Emerging Novel PI3K Inhibitors, Anti-CD20 mAb and Combination Therapy Options for Follicular Lymphoma
Released on 12/30/18
Expires on 12/30/19

Changing Landscape of Treatment Strategies of TKI Interruptions, Discontinuations and Switching in Patients with Chronic Myeloid Leukemia
Released on 12/30/18
Expires on 12/30/19

Update on Treatment Options for Acute Lymphoblastic Leukemia with An Emphasis on CD19, CD22 Monoclonal Antibodies and Anti-CD19 CAR T-cell Therapy
Released on 12/30/18
Expires on 12/30/19

Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer
Released on 11/7/18
Expires on 11/7/19

Emerging Treatment Options for Genomic Subgroups of Acute Myeloid Leukemia with IDH1/2, FLT3 and CD33 Targeted Agents
Released on 10/19/18
Expires on 10/19/19

Emerging Strategies in Novel Targeted Therapies for Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma)
Released on 9/28/18
Expires on 9/28/19

Emerging Novel Anti-CD20 mAb, PI3K Inhibitors and Combination Therapy Options for Follicular Lymphoma
Released on 8/15/18
Expires on 8/15/19

Mapping the Future Treatment Options with Multitargeted TKIs and Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma
Released on 8/15/18
Expires on 8/15/19

Mapping the Current and Future Treatment Options for Advanced Soft Tissue Sarcoma Including Liposarcoma and Leiomyosarcoma
Released on 8/15/18
Expires on 8/15/19

7th Annual Symposium on Current Strategies in the Treatment of Hodgkins Lymphoma, B-cell Lymphoma, Multiple Myeloma and Leukemia
Released on 7/2/18
Expires on 7/2/19

Immunotherapy with Anti-PD-1/PD-L1 Agents Are New Effective Therapies for Recurring and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Released on 6/29/18
Expires on- 6/29/19

Advances in the Treatment of Acute Lymphoblastic Leukemia with An Emphasis on CD22 and CD19 Monoclonal Antibodies
Released on 4/25/18
Expires on 4/25/19

Emerging Strategies in the Diagnosis, Treatment and the Concept of Treatment-free Remission in Chronic Myeloid Leukemia
Released on 12/28/17
Expires on 12/28/18

Changing Landscape of Novel Combination Therapies for Patients with Newly Diagnosed, Risk Stratified and Relapsed/Refractory Multiple Myeloma
Released on 12/20/17
Expires on 12/20/18

Emerging Checkpoint Inhibitor and Combination Based Therapies for Relapsed or Refractory Hodgkin's Lymphoma
Released on 12/20/17
Expires on 12/20/18

Update on Treatment Options for Leukemia: Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia
Released on 11/30/17
Expires on 11/30/18

Novel Therapeutic Approaches of EGFR-, ALK-rearranged Targeted Therapies and Immunotherapy of Lung Cancer
Released on 10/6/17
Expires on 10/6/18

Emerging Strategies in Targeted Therapy of Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
Released on 9/13/17
Expires on 9/13/18

Emerging Treatment Option with CDK 4/6 Inhibitors for Hormone Receptor-positive Breast Cancer: Insight into Clinical Activity and Safety Profile
Released on 8/8/17
Expires on 8/8/18

6th Annual Symposium on Current Strategies in the Treatment of Hodgkins Lymphoma, B-cell Lymphoma, Multiple Myeloma and Leukemia
Released on 7/28/17
Expires on 7/28/18

Emerging Strategies in the Treatment of Metastatic Urothelial Bladder Carcinoma: Outlook for 2017
Released on 7/26/17
Expires on 7/26/18

Emerging Treatment Options for Metastatic Renal Cell Carcinoma
Released on 5/11/17
Expires on 5/11/18

Changing Paradigms in the Diagnosis and Treatment of Multiple Myeloma
Released on 3/10/2017
Expired on 3/10/2018

Update on Immunotherapy Options for Non-Small Cell Lung Cancer
Released on 3/6/17
Expires on 3/6/18

Practice Changing Shift in Treatment Strategies for Advanced Soft Tissue Sarcoma, Liposarcoma and Leiomyosarcoma
Released on 2/16/17
Expires on 2/16/18

Practice Changing Treatment with CDK 4/6 Inhibitors for Hormone Receptor‐Positive Breast Cancer
Released on 12/30/16
Expires on 12/30/17

Emerging Strategies in Treatment of Hodgkin Lymphoma and Non‐Hodgkin Lymphoma
Released on 12/29/16
Expires on 12/29/17

Emerging Immunotherapy Options for Relapsed or Refractory Hodgkin's Lymphoma
Released on 12/20/16
Expires on 12/20/17

Novel Therapeutic Approaches for Patients with Squamous Cell Carcinoma of the Head and Neck
Released on 11/15/16
Expires on 11/15/17

Novel Treatment Approaches for Non-Small-Cell Lung Cancer: A 2016 Update
Released on 10/25/16
Expires on 10/25/17

Novel Therapeutic Options for Acute Lymphoblastic Leukemia
Released on 7/21/16
Expires on 7/21/17

Advances in the Treatment Options for Liposarcoma/Leiomyosarcoma and Soft Tissue Sarcoma
Released on 7/21/16
Expires on 7/21/17

Novel Therapies for Malignant Melanoma: Immune Checkpoint Inhibitors, Targeted BRAF Inhibitors and Oncolytic Viral Therapy Approaches
Released on 7/7/16
Expires on 7/7/17

Emerging Strategies in the Treatment of Chronic Lymphocytic Lymphoma
Released on 7/1/16
Expires on 7/7/17

Personalized, Genotype-directed Therapy for Advanced Non-Small Cell Lung Cancer
Released on 6/30/2016
Expires on 6/30/2017

Changing Landscape in the Treatment of Metastatic Renal Cell Carcinoma and Bladder Cancer: Newer Insights
Released on 6/30/2016
Expires on 6/30/2017

Molecular Prognostic and Predictive Biomarkers Based Targeted Treatment of Colorectal Cancer
Released on 6/30/2016
Expires on 6/30/2017

5th Annual Symposium on Current Strategies in the Management of B-cell Lymphomas, T-cell Lymphomas, Multiple Myeloma and Leukemia
Released on 6/27/2016
Expires on 6/27/2016